atropine has been researched along with Acanthamoeba Keratitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baig, AM | 1 |
| Das, S; Sahu, SK; Sharma, S; Vemuganti, GK | 1 |
| Agahan, AL; Lim, RB; Valenton, MJ | 1 |
1 review(s) available for atropine and Acanthamoeba Keratitis
| Article | Year |
|---|---|
Acanthamoeba keratitis presenting as a plaque.
Topics: Acanthamoeba Keratitis; Atropine; Biguanides; Ciprofloxacin; Cornea; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Ophthalmic Solutions | 2008 |
2 other study(ies) available for atropine and Acanthamoeba Keratitis
| Article | Year |
|---|---|
Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications.
Topics: Acanthamoeba Keratitis; Amebicides; Animals; Atropine; Drug Delivery Systems; Humans; Ophthalmoscopy; Treatment Outcome; Vision Disorders | 2019 |
Successful treatment of Acanthamoeba keratitis without anti-amoebic agents.
Topics: Acanthamoeba Keratitis; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Cornea; Diagnosis, Differential; Diclofenac; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Mydriatics; Ophthalmic Solutions; Retrospective Studies | 2009 |